Chicago-based physician to contribute through Anosh Inc Foundation and host local fundraiser in support of federal agents ...

The Anosh Foundation is a nonprofit organization dedicated to advancing ethical and accessible healthcare worldwide. Founded ...

SugarTop Buddery is known for its music and artist collaborations, stylish pre-rolls, and emphasis on social equity and women ...

TORONTO, July 09, 2025 (GLOBE NEWSWIRE) -- Today, the Healthcare of Ontario Pension Plan (HOOPP) is pleased to announce changes to its executive leadership team.

OXFORD, United Kingdom and MADISON, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, has been announced as the winner of the prestigious 2025 MacRobert ...

Candel was added to the Russell 2500 Value ® Index, Russell Small Cap Value ® Index, Russell 2000 Value ® Index, Russell Microcap Value ® Index, and Russell 3000E ® Value Index. Additionally, the ...

Additionally, the maturity dates of each of the Company’s three existing $10 million convertible notes payable to Mr. Uihlein and the aggregate borrowings of $81 million under several lines of credit, ...

(“LIXTE” or the “Company”) ( Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that the medical journal Nature has published findings by a team of physician-scientists ...

Dr. Edwin Tucker is departing his role as Chief Medical Officer effective August 1, 2025. Dr. Daniel Adelman, an experienced clinical development executive and member of Jasper’s scientific advisory ...

About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The company developed, commercialized and markets ...

About IPC Digital Health™ IPC Digital Health™ is the innovation arm of the Independent Pharmacy Cooperative, the country’s largest GPO owned by independent pharmacies. Through its iCare+™ platform, ...

Iambic to receive up to $25 million through a combination of upfront and expected near-term performance-based milestone payments for services related to Revolution Medicines’ access to Iambic’s ...